DOP2006000261A - DERIVATIVES OF 3-ALQUILAZETIDINA SUBSTITUTED WITH HETEROCICLES - Google Patents

DERIVATIVES OF 3-ALQUILAZETIDINA SUBSTITUTED WITH HETEROCICLES

Info

Publication number: DOP2006000261A
Authority: DO; Dominican Republic
Prior art keywords: alquilazetidina; heterocicles; derivatives; substituted; alquilazetidina substituted
Prior art date: 2005-11-28

Application number

DO2006000261A

Other languages

Spanish (es)

Inventor

Robert K Baker

Jeffrey J Hale

Shouwu Miao

Kathleen Rupprecht

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-28

Filing date

2006-11-23

Publication date

2007-07-15

2006-11-23 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

2007-07-15 Publication of DOP2006000261A publication Critical patent/DOP2006000261A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DO2006000261A 2005-11-28 2006-11-23 DERIVATIVES OF 3-ALQUILAZETIDINA SUBSTITUTED WITH HETEROCICLES DOP2006000261A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US74018305P	2005-11-28	2005-11-28

Publications (1)

Publication Number	Publication Date
DOP2006000261A true DOP2006000261A (en)	2007-07-15

Family

ID=37779312

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DO2006000261A DOP2006000261A (en)	2005-11-28	2006-11-23	DERIVATIVES OF 3-ALQUILAZETIDINA SUBSTITUTED WITH HETEROCICLES

Country Status (15)

Country	Link
EP (1)	EP1954692A1 (en)
KR (1)	KR20080073721A (en)
AR (1)	AR058199A1 (en)
BR (1)	BRPI0619018A2 (en)
CR (1)	CR10014A (en)
DO (1)	DOP2006000261A (en)
EC (1)	ECSP088477A (en)
IL (1)	IL191586A0 (en)
MA (1)	MA30086B1 (en)
NO (1)	NO20082919L (en)
PE (1)	PE20070647A1 (en)
RU (1)	RU2008126248A (en)
SV (1)	SV2009002917A (en)
TW (1)	TW200804317A (en)
WO (1)	WO2007062193A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7906652B2 (en)	2005-11-28	2011-03-15	Merck Sharp & Dohme Corp.	Heterocycle-substituted 3-alkyl azetidine derivatives
EP2025674A1 (en)	2007-08-15	2009-02-18	sanofi-aventis	Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
JP2011502119A (en) *	2007-10-24	2011-01-20	メルク・シャープ・エンド・ドーム・コーポレイション	Synthesis and crystals of CB-1 antagonist / inverse agonist
US9440948B2 (en)	2010-09-03	2016-09-13	University Of Florida Research Foundation, Inc.	Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
EP2766349B1 (en)	2011-03-08	2016-06-01	Sanofi	Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
WO2012120054A1 (en)	2011-03-08	2012-09-13	Sanofi	Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828995B2 (en)	2011-03-08	2014-09-09	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120055A1 (en)	2011-03-08	2012-09-13	Sanofi	Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2805817B1 (en) *	2000-03-03	2002-04-26	Aventis Pharma Sa	PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION
FR2805810B1 (en) *	2000-03-03	2002-04-26	Aventis Pharma Sa	PHARMACEUTICAL COMPOSITIONS CONTAINING 3- AMINO-AZETIDINE DERIVATIVES, THE NEW DERIVATIVES AND THEIR PREPARATION
FR2805818B1 (en) *	2000-03-03	2002-04-26	Aventis Pharma Sa	AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU2006100298A (en) *	2003-06-11	2006-05-10	Мерк энд Ко., Инк. (US)	SUBSTITUTED 3-ALKYL-AND 3-ALKENYLASETIDINE DERIVATIVES
WO2006119260A2 (en) *	2005-05-02	2006-11-09	Merck & Co., Inc.	Combination of dipeptidyl peptidase-iv inhibitor and a cannabinoid cb1 receptor antagonist for the treatment of diabetes and obesity

2006
- 2006-11-20 AR ARP060105076A patent/AR058199A1/en unknown
- 2006-11-22 WO PCT/US2006/045328 patent/WO2007062193A1/en active Application Filing
- 2006-11-22 KR KR1020087012880A patent/KR20080073721A/en not_active Application Discontinuation
- 2006-11-22 BR BRPI0619018A patent/BRPI0619018A2/en not_active IP Right Cessation
- 2006-11-22 EP EP06838347A patent/EP1954692A1/en not_active Withdrawn
- 2006-11-22 RU RU2008126248/04A patent/RU2008126248A/en not_active Application Discontinuation
- 2006-11-22 TW TW095143274A patent/TW200804317A/en unknown
- 2006-11-23 DO DO2006000261A patent/DOP2006000261A/en unknown
- 2006-11-23 PE PE2006001495A patent/PE20070647A1/en not_active Application Discontinuation
2008
- 2008-05-20 IL IL191586A patent/IL191586A0/en unknown
- 2008-05-22 CR CR10014A patent/CR10014A/en not_active Application Discontinuation
- 2008-05-27 EC EC2008008477A patent/ECSP088477A/en unknown
- 2008-05-28 SV SV2008002917A patent/SV2009002917A/en not_active Application Discontinuation
- 2008-06-25 MA MA31075A patent/MA30086B1/en unknown
- 2008-06-27 NO NO20082919A patent/NO20082919L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
RU2008126248A (en)	2010-01-10
ECSP088477A (en)	2008-06-30
CR10014A (en)	2008-07-29
KR20080073721A (en)	2008-08-11
IL191586A0 (en)	2008-12-29
PE20070647A1 (en)	2007-08-11
BRPI0619018A2 (en)	2016-11-29
AR058199A1 (en)	2008-01-23
WO2007062193A1 (en)	2007-05-31
TW200804317A (en)	2008-01-16
MA30086B1 (en)	2008-12-01
EP1954692A1 (en)	2008-08-13
NO20082919L (en)	2008-08-27
SV2009002917A (en)	2009-02-19

Publication	Publication Date	Title
FR20C1027I2 (en)	2021-06-11	DERIVATIVES OF TIGLIEN-3-ONE
DOP2007000084A (en)	2007-12-31	DERIVATIVES OF DIHYDROPIRAZOLOPIRIMIDINONE
CR10813A (en)	2009-08-12	ISOQUINOLONE DERIVATIVES SUBSTITUTED WITH CICLOALQUILAMINA
ATE483711T1 (en)	2010-10-15	SPIROINDOLINONE DERIVATIVES
ATE469905T1 (en)	2010-06-15	PYRIDOPYRIMIDINONE DERIVATIVES
ATE512135T1 (en)	2011-06-15	SPIROINDOLINONE DERIVATIVES
DK2035394T3 (en)	2009-10-05	2-pyrazinecarboxamide derivatives
DE602006010581D1 (en)	2009-12-31	4-PHENYL-6-SUBSTITUTED PYRIMIDIN-2-CARBONITRILE DERIVATIVES
CR9779A (en)	2008-09-17	FUNGICIDE DERIVATIVES OF PHENYLAMIDINE REPLACED WITH PIRIDINYLOXY
CR10562A (en)	2009-03-20	NEW DERIVATIVES OF PIRIDAZINA
EP1896395A4 (en)	2010-12-01	MODIFIED MALONATE DERIVATIVES
BRPI0714764A2 (en)	2014-12-30	SUBSTITUTED SULFONAMIDE DERIVATIVES
ATE485294T1 (en)	2010-11-15	AZAINDOL-2-CARBOXAMIDE DERIVATIVES
ATE487718T1 (en)	2010-11-15	SUBSTITUTED BIZYCLIC PYRIMIDONE DERIVATIVES
ATE527255T1 (en)	2011-10-15	ARYL-ISOXAZOLE-4-YL-IMIDAZOLE DERIVATIVES
EP1906944A4 (en)	2010-08-04	PREPARATION OF SCHISANDRINE B
ATE544764T1 (en)	2012-02-15	5-HYDROXYMETHYLOXAZOLIDINE-2-ONE DERIVATIVES
FR2902426B1 (en)	2008-09-05	CINNAMOYL-PIPERAZINE DERIVATIVES
CR10809A (en)	2009-06-25	DERIVATIVES OF HETEROARIL-PIRROLIDINIL-Y-PIPERIDINIL-CETONA
DOP2006000261A (en)	2007-07-15	DERIVATIVES OF 3-ALQUILAZETIDINA SUBSTITUTED WITH HETEROCICLES
NO20055643D0 (en)	2005-11-29	Preparation of lodixanol
DE602006014973D1 (en)	2010-07-29	NOVEL CERCOSPORAMIDE DERIVATIVES
EP1867636A4 (en)	2010-06-02	PYRIDYLMETHYLSULFONE DERIVATIVE
ATE541837T1 (en)	2012-02-15	OXAPHENANTHRENE DERIVATIVES
EP1935879A4 (en)	2011-07-06	SUBSTITUTED CYCLOALCENE DERIVATIVE